ANDERSON A SCOTT
Known title: Exec VP andCIK: 0001184825
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Merit Medical Systems sets Q3 2026 earnings date. Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.
Transaction History
| ZION | ▼ Sell | Tax Withholding | 659 | $26K | 2/13/2024 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 1,046 | $43K | 2/12/2024 | View on chart |
| ZION | ▲ Buy | Grant | 9,485 | $391K | 2/12/2024 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 361 | $14K | 2/8/2024 | View on chart |
| ZION | ▼ Sell | Open Market | 392 | $15K | 2/6/2024 | View on chart |
| ZION | ▼ Sell | Open Market | 440 | $17K | 2/6/2024 | View on chart |
| ZION | ▼ Sell | Open Market | 4,093 | $181K | 1/26/2024 | View on chart |
| ZION | ▼ Sell | Open Market | 256 | $10K | 12/19/2023 | View on chart |
| MMSI | ▼ Sell | Gift | 2,820 | $0 | 8/14/2023 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 25,000 | $1.3M | 8/9/2023 | View on chart |
| MMSI | ▼ Sell | Open Market | 22,180 | $1.5M | 8/9/2023 | View on chart |
| MMSI | ▲ Buy | Grant | 2,262 | $0 | 5/18/2023 | View on chart |
| MMSI | ▼ Sell | Gift | 3,000 | $0 | 3/7/2023 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 5,000 | $94K | 3/6/2023 | View on chart |
| MMSI | ▲ Buy | Option Exercise | 10,000 | $344K | 3/6/2023 | View on chart |
| MMSI | ▼ Sell | Open Market | 15,000 | $1.0M | 3/6/2023 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 404 | $20K | 3/1/2023 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 296 | $16K | 2/13/2023 | View on chart |
| ZION | ▲ Buy | Grant | 6,318 | $334K | 2/13/2023 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 494 | $26K | 2/10/2023 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 461 | $24K | 2/10/2023 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 179 | $9K | 12/23/2022 | View on chart |
| ZION | ▼ Sell | Open Market | 2,030 | $101K | 11/8/2022 | View on chart |
| ZION | ▲ Buy | Option Exercise | 4,249 | $89K | 11/8/2022 | View on chart |
| ZION | ▼ Sell | Open Market | 8,495 | $423K | 11/8/2022 | View on chart |
| ZION | ▼ Sell | Open Market | 4,249 | $212K | 11/8/2022 | View on chart |
| ZION | ▲ Buy | Option Exercise | 8,495 | $178K | 11/8/2022 | View on chart |
| MMSI | ▲ Buy | Grant | 3,050 | $0 | 5/24/2022 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 632 | $41K | 3/1/2022 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 543 | $38K | 2/23/2022 | View on chart |
| ZION | ▲ Buy | Option Exercise | 3,445 | $100K | 2/14/2022 | View on chart |
| ZION | ▲ Buy | Option Exercise | 14,470 | $420K | 2/14/2022 | View on chart |
| ZION | ▼ Sell | Open Market | 14,470 | $1.0M | 2/14/2022 | View on chart |
| ZION | ▼ Sell | Open Market | 3,445 | $248K | 2/14/2022 | View on chart |
| ZION | ▼ Sell | Open Market | 12,788 | $918K | 2/14/2022 | View on chart |
| ZION | ▲ Buy | Grant | 4,402 | $322K | 2/11/2022 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 720 | $53K | 2/10/2022 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 566 | $42K | 2/8/2022 | View on chart |
| ZION | ▼ Sell | Tax Withholding | 261 | $16K | 12/20/2021 | View on chart |
| ZION | ▼ Sell | Open Market | 1,520 | $100K | 11/8/2021 | View on chart |
| ZION | ▼ Sell | Gift | 2,375 | $0 | 11/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Zions Bancorp Analysts Cut Targets Amid Fed Policy Shift
Several major banks lowered their price targets for Zions Bancorp, with JP Morgan, Evercore ISI, and Piper Sandler all reducing expectations to the mid‑$60s. The cuts come as the Fed considers raising asset thresholds, which could tighten regulatory capital for regional banks. Despite the downward revisions, Zions has posted a 14.8% gain over the past six months and remains near its 200‑day moving‑average support at $61.72.
Zions Bancorp Analysts Cut Targets Amid Fed Policy Shift. Several major banks lowered their price targets for Zions Bancorp, with JP Morgan, Evercore ISI, and Piper Sandler all reducing expectations to the mid‑$60s. The cuts come as the Fed considers raising asset thresholds, which could tighten regulatory capital for regional banks. Despite the downward revisions, Zions has posted a 14.8% gain over the past six months and remains near its 200‑day moving‑average support at $61.72.